Copyright © 2011-2016 Ascletis Inc. All rights reserved.
ASCLETIS
Home

中文

News & Events

Investor Center

Careers

Pipeline

Partnership

About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Contact
Contact    Home    Home-Ch
ABOUT US

Corporate Overview

Management Team

Board of Directors

Founders

Management Team Board of Directors Founders About Us

12/02/2015       Deputy Governor, Mrs. Liming Liang meets with Dr. Wu and  top executives from Goldman Sachs


12/02/2015       Hangzhou and Shaoxing, China – Goldman Sachs Invested US$20 Million in Ascletis


10/19/2015       Dr. Wu was Invited to Spoke at the Gates Foundation 11 th Annual Grand Challenges Conference


09/02/2015       Ascletis Secures US$35 Million Financing


08/31/2015       Ascletis Initiates Phase II Clinical Trial of Its Interferon-Free HCV Combination Regimen in Taiwan


06/24/2015       Ascletis as the First Chinese Co. to File Clinical Applications for Interferon-Free HCV Treatment


04/16/2015       Ascletis featured in Healthcare Executive: Drug Innovation in China Style


04/13/2015       Special report of Ascletis by BioCentury: HCV Race in China


03/23/2015       BioWorld Today - Ascletis’ triple therapy HCV drug nails phase II trial in Chinese patients


03/19/2015       Special report of Ascletis’ ASC08 by Zhejiang Dailly on China’s National Liver Day


03/18/2015       Ascletis’s HCV Drug ASC08 phase 2 data presented at annual APASL


11/10/2014       Ascletis gains exclusive China market rights from Presidio to HCV NS5A inhibitor PPI-668


10/28/2014       Ascletis to build commercial cGMP facility in Shaoxing Binhai New City


06/09/2014       Ascletis featured in the interview of Dr. Darren Ji, Vice President of Roche by Med Eco News


05/09/2014       Ascletis presents at the third Asia Conference of Hepatitis and HIV in Beijing, China


04/30/2013       Ascletis gains China market rights from Janssen to a clinical stage HIV protease inhibitor


04/15/2013       Roche and Ascletis enter collaboration to advance HCV treatment options for Chinese patients


03/14/2013       Dr. Jinzi Wu invited to present at the 3rd Annual China Healthcare Investment Conference


10/23/2012       Dr. Jinzi Wu invited to speak at the BIO convention in China  


07/12/2012       Alnylam and Ascletis form a strategic collaboration to develop ALN-VSP for liver cancer patients


07/10/2012       Prof. Kit Lam of the UC Davis visits Ascletis  and gives the keynote lecture


04/16/2012       Dr.Jinzi  Wu  is invited to speak at the 15th annual Harvard China Forum (HCF)


01/26/2012       Dr. Jinzi Wu is invited to attend  the Executive Roundtable with the US Surgeon General  


01/04/2012       Ascletis receives record-level research and development grant from Hangzhou, China


10/20/2011       The party secretary of ZJ Province, Mr. Zhao, and the governor of NC, Mrs. Perdue, visit Ascletis


09/30/2011       The party secretary, Mr. Zhang, and the deputy director , Mr. Wu of the HHTZ, visit Ascletis


07/20/2011       Ascletis announces new support from Hangzhou, China and the Hamner Institutes in RTP, NC


07/11/2011       Ascletis names Allan Baxter, former GSK Global Head of  Medicines Development, as CSO


06/22/2011       Dr. Jinzi Wu is invited to speak at 2011 Bio International Convention


04/25/2011       Meeting with Tong Gui-Li, Deputy Mayor of Hangzhou Government, Mrs. Tong

N03142013 N01042012 N01262012 N04162012 N07122012 N07102012 N10232012 N04252011 N10202011(2) N09302011 N04152013 N04302013 N05092014 N06092014 N10282014 N03182015 N06222011 N07112011 N07202011 N11102014 BioWorld20150323.pdf 20150319ZhejiangDailyCh.pdf 20150416HealthcareExecutiveCh.pdf 20150413BioCentury.pdf 20150624IFN-free.pdf 20150831IFN-free.pdf 20150902Financing.pdf 20151019GrandChallenge.pdf 20151202GS.pdf 20151203DeputyGovernorCh.pdf

NEWS & EVENTS 2011-2015

Current News >>  

News & Events